Employment of a director's son-in-law by Abbott, with total compensation exceeding the policy review threshold.
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Robert B. Ford
Also a director
Chairman of the Board and Chief Executive Officer, and Director
|
52 |
Since 2021
5 years
|
$24,198,660 | |
|
Philip P. Boudreau
Executive Vice President, Finance and Chief Financial Officer
|
53 |
Since 2024
2 years
|
$9,090,636 | |
|
Elizabeth C. Cushman
Executive Vice President, General Counsel and Secretary
|
56 |
Since 2025
1 year
|
Not reported | |
|
Lisa D. Earnhardt
Executive Vice President and Group President, Medical Devices
|
56 |
Since 2023
3 years
|
$8,069,724 | |
|
Daniel Salvadori
Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products
|
47 |
Since 2021
5 years
|
$6,534,285 | |
|
Mary K. Moreland
Executive Vice President, Human Resources
|
59 |
Since 2019
7 years
|
Not reported | |
|
Louis H. Morrone
Executive Vice President, Core Diagnostics
|
49 |
Since 2023
3 years
|
Not reported | |
|
Christopher J. Scoggins
Executive Vice President, Diabetes Care
|
56 |
Since 2025
1 year
|
$6,601,667 | |
|
Eric Shroff
Senior Vice President, Rapid and Molecular Diagnostics
|
54 |
Since 2025
1 year
|
Not reported | |
|
Jacob A Orville
Senior Vice President
Title from the Form 4 dated Mar 23, 2026
|
Not stated | Not stated | Not reported | |
|
John A. McCoy, Jr.
Vice President, Finance and Controller
|
56 |
Since 2023
3 years
|
Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Mar 13, 2026 · updated by the 8-K of Apr 27, 2026
| Director | Age | On board | Independent | Committees | Other public boards | Pay | Source |
|---|---|---|---|---|---|---|---|
|
Robert B. Ford
Board chair, CEO
|
52 |
2019
7 years
|
Not independent |
•Executive · Chair
|
None stated | Paid as CEO | |
|
Nancy McKinstry
Lead independent director
|
67 |
2011
15 years
|
Independent |
•Audit · Chair
•Compensation
•Executive
|
Accenture plc, Mondelēz International, Inc. | Not stated | |
|
Nita Ahuja, M.D.
|
59 |
2025
1 year
|
Independent | None stated | None stated | Not stated | |
|
Claire Babineaux-Fontenot
|
61 |
2022
4 years
|
Independent | None stated | None stated | Not stated | |
|
Sally E. Blount, Ph.D.
|
64 |
2011
15 years
|
Independent | None stated | None stated | Not stated | |
|
Paola Gonzalez
|
54 |
2021
5 years
|
Independent |
•Audit
•Nominations and Governance
|
None stated | Not stated | |
|
Michelle A. Kumbier
|
58 |
2018
8 years
|
Independent |
•Audit
•Compensation
|
Teledyne Technologies Incorporated, Ryerson Holding Corporation | Not stated | |
|
Darren W. McDew
|
65 |
2019
7 years
|
Independent | None stated | Parsons Corporation, GE Aerospace | Not stated | |
|
Michael G. O’Grady
|
60 |
2023
3 years
|
Independent |
•Compensation
•Nominations and Governance
|
Northern Trust Corporation | Not stated | |
|
Michael F. Roman
|
66 |
2021
5 years
|
Independent | None stated | Waystar Holding Corp. | Not stated | |
|
Daniel J. Starks
|
71 |
2017
9 years
|
Independent | None stated | None stated | Not stated | |
|
John G. Stratton
|
65 |
2017
9 years
|
Independent |
•Audit
•Nominations and Governance · Chair
•Executive
|
General Dynamics Corporation | Not stated | |
|
Kevin Conroy
Joined Apr 24, 2026
|
- | - | - | - | - | - | |
|
Robert J. Alpern, M.D.
Leaving at the meeting
|
Not stated | Not stated | Independent | None stated | None stated | Not stated |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Employment of a director's son-in-law by Abbott, with total compensation exceeding the policy review threshold.
Loading...